1. Home
  2. Stocks
  3. Wanbury Share Price

WANBURY

Small Cap BSE: 524212 NSE: WANBURY
₹64.45
-3.35 (-4.94%)
As on 16 August, 2022 | 08:41
Announcements

Wanbury Share Price

Advance Charts

Wanbury Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume
Share Returns Investment Rating Financials
More
Technicals Resistance and Support Delivery and Volume Result Highlights Synopsis Corporate Action MF Shareholding Similar Stocks News FAQs

Wanbury Share Returns

  • Over 1 Month 1.1%
  • Over 3 Month -5.07%
  • Over 6 Month -32.73%
  • Over 1 Year -23.02%

Wanbury Key Statistics

P/E Ratio 2.8
PEG Ratio 0
Market Cap Cr 211
Price to Book Ratio -9
EPS 1.6
Dividend 0
Relative Strength Index 46.9
Money Flow Index 56.03
MACD Signal 0.64
Average True Range 2.9

Wanbury Investment Rating

  • Master Rating:

  • Wanbury has an operating revenue of Rs. 500.26 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 16% is great, ROE of -347% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 96 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Wanbury Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 117
  • 134
  • 125
  • 124
  • 128
  • 120
  • Operating Expenses Qtr Cr
  • 120
  • 122
  • 116
  • 117
  • 121
  • 122
  • Operating Profit Qtr Cr
  • -3
  • 13
  • 9
  • 7
  • 7
  • -2
  • Depreciation Qtr Cr
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • Interest Qtr Cr
  • 3
  • 5
  • 6
  • 5
  • 5
  • 6
  • Tax Qtr Cr
  • 0
  • -1
  • 0
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • -7
  • 83
  • 0
  • -1
  • -1
  • -9

Wanbury Technicals

EMA & SMA

Current Price
64.55
-3.25 (-4.79%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • 66.36
  • 50 Day
  • 66.63
  • 100 Day
  • 69.68
  • 200 Day
  • 76.51
  • 20 Day
  • 65.85
  • 50 Day
  • 64.39
  • 100 Day
  • 71.09
  • 200 Day
  • 76.59

Wanbury Resistance and Support

PIVOT
₹67.87
Resistance
  • First Resistance
  • 67.94
  • Second Resistance
  • 68.07
  • Third Resistance
  • 68.14
Support
  • First Resistance
  • 67.74
  • Second Resistance
  • 67.67
  • Third Resistance
  • 67.54
  • RSI
  • 46.9
  • MFI
  • 56.03
  • MACD Single Line
  • 0.64
  • MACD
  • 0.9

Wanbury Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 22,939
  • 2,293,900
  • 100
  • Week
  • 29,358
  • 2,935,750
  • 100
  • 1 Month
  • 30,574
  • 3,057,433
  • 100
  • 6 Month
  • 26,442
  • 2,644,173
  • 100

Wanbury Result Highlights

Wanbury Synopsis

NSE-Medical-Generic Drugs

Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 511.19 Cr. and Equity Capital is Rs. 32.67 Cr. for the Year ended 31/03/2022. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.
  • Market Cap
  • 211
  • Sales
  • 500
  • Shares in Float
  • 1.96
  • No of funds
  • 3
  • Yield
  • Book Value
  • 96.34
  • U/D Vol ratio
  • 2
  • LTDebt / Equity
  • Alpha
  • -0.08
  • Beta
  • 0.65

Wanbury

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 39.85%
  • 39.89%
  • 39.89%
  • Mutual Funds
  • Financial Institutions/ Banks
  • Individual Investors
  • 38.42%
  • 38.15%
  • 37.9%
  • Others
  • 21.73%
  • 21.96%
  • 22.21%

Wanbury Management

  • Name
  • Designation
  • Mr. K Chandran
  • Vice Chairman & Whole Time Dir
  • Mr. N K Puri
  • Ind. Non-Executive Director
  • Mr. S K Bhattacharya
  • Ind. Non-Executive Director
  • Ms. Pallavi P Shedge
  • Ind. Non-Executive Director
  • Mr. Binod Chandra Maharana
  • Ind. Non-Executive Director
  • Dr. Manisha Juvekar
  • Ind. Non-Executive Director

Wanbury Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Wanbury Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-10
  • Quarterly Results
  • 2022-06-22
  • Audited Results
  • 2022-02-17
  • Preferential issue of shares
  • 2022-02-08
  • Quarterly Results
  • 2021-11-25
  • Quarterly Results
  • (Revised)

Wanbury FAQs

What is Share Price of Wanbury ?

Wanbury share price is ₹64 As on 16 August, 2022 | 08:27

What is the Market Cap of Wanbury ?

The Market Cap of Wanbury is ₹210.7 Cr As on 16 August, 2022 | 08:27

What is the P/E ratio of Wanbury ?

The P/E ratio of Wanbury is 2.8 As on 16 August, 2022 | 08:27

What is the PB ratio of Wanbury ?

The PB ratio of Wanbury is -9 As on 16 August, 2022 | 08:27

Q1FY23
Open Demat Account